Consequently, these findings imply that FCN2 may suppress the HCC tumor immune response by favorably regulating neutrophils (19, 20), eosinophils (21), NK cells (22–24), Tcm (25), and DCs (26–28) and negatively regulating Th2 (29–31) in tumors. Here, FCN2 is linked to neoplasm.